Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111606785B details a green, Pd-free method for aryl internal alkynes using copper catalysis and visible light, offering significant cost and supply chain advantages.
Patent CN110803985A discloses a safe, scalable synthesis of Bilastine intermediate II using vinyl sulfate, avoiding toxic ethylene oxide and expensive noble metal catalysts.
Patent CN102249900B reveals novel esterification separation for adamantane isomers. Enhances purity and reduces waste for pharmaceutical intermediate supply chains.
Novel U-shaped template strategy for meta-C-H olefination. Reduces steps and costs for API intermediates. High purity and scalability for pharmaceutical manufacturing.
Patent CN118684552A enables direct trifluoromethylation of electron-deficient rings at room temperature. Discover cost-effective supply chain solutions.
Novel magnesium-catalyzed asymmetric allylation for Sitagliptin intermediate. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers.
Patent CN114805231A reveals a high-yield, eco-friendly synthesis for p-NH2-Bn-NOTA, offering significant cost reduction and supply chain reliability for radiopharmaceutical manufacturers.
Patent CN101417945A reveals a greener copper-catalyzed route for 4-bromo-2,3,5,6-tetrafluorophenylacetic acid, offering significant cost and safety advantages for pharmaceutical supply chains.
Patent CN101735118B details a silane-protected route for tert-butylsulfinamide, offering mild conditions and high purity for chiral amine synthesis.
Patent CN106831584B details a Pd-catalyzed route for pyrazoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101553477A reveals a novel route for L-gluconic acid production, offering cost reduction in API manufacturing through improved yields and shorter reaction times.
Patent CN106946682A reveals a metal-free route for propiolic acid synthesis using CO2. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Novel Rh-catalyzed route for 1-naphthol phosphine oxide ligands. High yield, mild conditions. Cost-effective manufacturing for pharma intermediates.
Novel route for chlorantraniliprole key intermediate avoids benzoxazinone formation. High yield, low cost, scalable process for agrochemical manufacturing.
Novel electro-reduction method for telmisartan intermediates eliminates heavy metals, ensuring high purity and cost-effective scalable manufacturing for global API supply chains.
Patent CN109503656A reveals a cesium carbonate catalyzed route for high-purity chiral organophosphonates. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102285919A reveals a gold-catalyzed route for 4-fluoro pyrazoles. Mild conditions, high yields, and broad substrate scope ensure cost-effective manufacturing for pharma intermediates.
Patent CN112142796A details a mild synthesis of isoquinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113307780B details a green synthesis of 2-amino-1,3,4-oxadiazoles using KHSO4. This report analyzes cost reduction and scalability for pharmaceutical intermediate suppliers.
Patent CN1155603C reveals a novel phenol-based deprotection route for 3-cephem compounds, offering high-purity antibiotic intermediates with significant cost reduction in API manufacturing.